Board and Advisors
Maurizio Fava, M.D.
Director of the Division of Clinical Research of the Massachusetts General Hospital (MGH) Research institute, Executive Vice Chair of the MGH Department Psychiatry, Executive Director of the MGH Clinical Trials Network & Institute (CTNI), a Harvard teaching hospital; associate member of the Broad Institute’s Stanley Center for Psychiatric Research; Slater Family Professor of Psychiatry at Harvard Medical School. Dr. Fava has received several awards, including the 2015 Depression and Bipolar Support Alliance (DBSA) Senior Investigator Gerald L. Klerman Award. He is the immediate past president of the American Society of Clinical Psychopharmacology and is on the editorial board of five international medical journals, including the Journal of Affective Disorders and the Journal of Clinical Psychiatry.
Aimee Danielson, Ph.D.
Founder and Director of the Women’s Mental Health Program at MedStar Georgetown University Hospital, an outpatient treatment program in Washington, DC, devoted exclusively to treating perinatal psychiatric disorders. Dr. Danielson is an Assistant Professor of Clinical Psychiatry at Georgetown University School of Medicine, and actively involved in medical education. She teaches medical students, residents and fellows about women’s mental health, including the motherhood transition and perinatal psychiatric disorders. Dr. Danielson is co-founder of the DC Women’s Reproductive Mental Health Consortium and also an active member of the DC Collaborative for Mental Health in Pediatric Primary Care.
Harry Leider, M.D., MBA
Chief Medical Officer and Group Vice President of Walgreens. Before joining Walgreens, Dr. Leider was Chief Medical Officer of Ameritox, and prior to that he was Chief Medical Officer of XLHealth. Leider also served as the Chief Medical Officer for HealthNet and was a physician executive at Harvard Pilgrim Health Plan. Dr. Leider is on the editorial boards of Physician Executive and the Journal of Population Health Management. He is also a founding board member of the Disease Management Association of America (DMAA) and served on the board of the Institute of Aging at the University of Pennsylvania. Dr. Lieder also served for six years as an attending physician at Brigham and Women’s Hospital and faculty member at Harvard Medical School, and more recently as a faculty member at the Johns Hopkins Carey School of Business.
Helen Christensen, Ph.D.
Director and Chief Scientist of the Black Dog Institute; Professor of Mental Health at the University of New South Wales; National Health and Medical Research Council (NHMRC) John Cade Research Fellow; member of the Academy of Social Sciences, Australia; past President of the Australasian Society for Psychiatric Research; immediate past President of the International Society for Research in Internet Interventions. Dr. Christensen is also the Chief Investigator for the NHMRC Clinical Research Centre for Excellence in Suicide Prevention.
Ian Gotlib, Ph.D.
David Starr Jordan Professor and Chair of the Department of Psychology at Stanford University and Director of the Stanford Mood and Anxiety Disorders Laboratory. Dr. Gotlib studies depression and risk for disorder in children, adolescents and adults. He has received the Distinguished Investigator Award from the National Alliance for Research in Schizophrenia and Affective Disorders, the Joseph Zubin Award for lifetime research contributions to the understanding of psychopathology, the APA Award for Distinguished Scientific Contribution and the APS Distinguished Scientist Award.
Julien Epps, Ph.D.
Associate Professor in Signal Processing with the School of Electrical Engineering and Telecommunications at UNSW Australia and Contributed Principal Researcher with Data61, CSIRO, Australia